查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609087

分子检测法市场：按技术、按产品划分 - 2025-2030 年全球预测

Molecular Methods Market by Technology (Biosensors, Immunoassay, Microarray), Product (Instrument, Reagents & Consumables, Services) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年分子检测法市场价值为22.9亿美元，预计到2024年将达到24.2亿美元，复合年增长率为6.83%，到2030年将达到36.4亿美元。

分子检测法市场包括分子生物学中使用的各种技术，主要集中于核酸和蛋白质的分析，以促进生物标记的检测、表征和定量。这些技术包括聚合酵素链锁反应(PCR)、定序技术、微阵列以及医疗保健、农业、环境研究和製药等各个领域所必需的其他先进生化技术。对个人化医疗、标靶治疗和旨在提高治疗效果和患者预后的先进诊断工具的需求不断增长，推动了对分子检测法的需求。其用途范围从研究和基因组研究到临床诊断和药物开发。最终用户包括医院、研究机构、生技公司、农业等。影响市场的关键成长要素包括定序和生物资讯学的技术进步、精准医学的兴起以及基因研究资金的增加。此外，COVID-19 大流行凸显了分子诊断和加速市场采用的重要性。 CRISPR 技术的扩展、次世代定序仪(NGS) 应用的开发以及生物标记的发现存在潜在的商机。然而，高成本、监管障碍和对熟练人员的需求等挑战阻碍了市场的加速成长。创新和研究最好针对自动化，以降低成本并提高可访问性，利用人工智慧增强资料分析能力，并探索合成生物学和基因编辑的新颖应用。市场格局是动态的，对于能够应对技术复杂性和监管环境的公司来说，存在着巨大的机会。鼓励公司透过投资伙伴关係和研究合作、利用新兴技术以及为利基和更广泛的应用开发全面的解决方案来满足未来的市场需求。

主要市场统计
基准年[2023] 22.9亿美元
预计年份 [2024] 24.2亿美元
预测年份 [2030] 36.4亿美元
复合年增长率（%） 6.83%

市场动态：揭示快速发展的分子检测法市场的关键市场洞察

供需的动态交互作用正在改变分子检测法市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 食品安全需求不断成长
    • 感染疾病流行率不断上升
    • 环境工程的应用不断增加
  • 市场限制因素
    • 严格的审批监管标准
  • 市场机会
    • 分子技术的持续研发与进步
    • 基因组研究进展
  • 市场挑战
    • 分子检测法的本质局限性

波特五力：驾驭分子检测法市场的策略工具

波特的五力架构是了解分子检测法市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解分子检测法市场的外部影响

外部宏观环境因素在塑造分子检测法市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解分子检测法市场的竞争状况

分子检测法市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵分子检测法市场供应商的绩效评估

FPNV定位矩阵是评估分子检测法市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了检测法市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，分子检测法市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 食品安全需求不断成长
      • 感染疾病传播加剧
      • 环境工程的应用不断增加
    • 抑制因素
      • 严格的核准监管标准
    • 机会
      • 分子技术的持续研究、开发与进步
      • 基因组学领域发展加速
    • 任务
      • 分子检测法的固有局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章分子检测法市场：依技术分类

  • 生物感测器
  • 免疫检测
  • 微阵列
  • 聚合酵素链锁反应

第七章分子检测法市场：副产品

  • 装置
  • 试剂/耗材
  • 服务

第八章美洲分子检测法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区分子检测法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的分子检测法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3m Company
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • HiMedia Laboratories LLC
  • Invitae Corporation
  • Neogen Corporation
  • QIAGEN GmbH
  • Sekisui Chemical Co., Ltd.
  • SGS SA
  • Siemens AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD8981BF

The Molecular Methods Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.42 billion in 2024, and is projected to grow at a CAGR of 6.83%, to USD 3.64 billion by 2030.

The molecular methods market encompasses various techniques used in molecular biology, primarily focusing on the analysis of nucleic acids and proteins, to facilitate the detection, characterization, or quantification of biomarkers. These methods include polymerase chain reaction (PCR), sequencing technologies, microarrays, and other sophisticated biochemical methods that are essential across various sectors such as healthcare, agriculture, environmental studies, and pharmaceuticals. The necessity of molecular methods is driven by the growing demand for personalized medicine, targeted therapies, and advanced diagnostic tools aiming to enhance treatment efficacy and patient outcomes. Applications range from research and genomic studies to clinical diagnostics and pharmaceutical development. End-users include hospitals, research institutions, biotechnology firms, and agricultural industries, among others. Key growth factors influencing the market include technological advancements in sequencing and bioinformatics, the rise of precision medicine, and increased funding for genetic research. Additionally, the COVID-19 pandemic has underscored the importance of molecular diagnostics, accelerating market adoption. Potential opportunities lie in the expansion of CRISPR technology, development of next-generation sequencing (NGS) applications, and biomarker discovery. However, challenges such as high costs, regulatory hurdles, and the need for skilled personnel impede faster market growth. Innovation and research are best directed at automating molecular methods to reduce costs and improve accessibility, enhancing data analysis capabilities through AI, and exploring novel applications in synthetic biology and gene editing. The market's nature is dynamic, with significant opportunities for those who can navigate technological complexities and regulatory landscapes. Companies are advised to invest in partnerships and research collaborations to capitalize on emerging technologies and develop comprehensive solutions that serve both niche and broad applications, thereby aligning with future market demands.

KEY MARKET STATISTICS
Base Year [2023] USD 2.29 billion
Estimated Year [2024] USD 2.42 billion
Forecast Year [2030] USD 3.64 billion
CAGR (%) 6.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Methods Market

The Molecular Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for food safety
    • Rising prevalence of infectious diseases
    • Increasing applications in environmental engineering
  • Market Restraints
    • Stringent regulatory norms for approval
  • Market Opportunities
    • Ongoing R&D and advancements in molecular techniques
    • Rising developments in genomics filed
  • Market Challenges
    • Intrinsic limitations of molecular methods

Porter's Five Forces: A Strategic Tool for Navigating the Molecular Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Molecular Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Molecular Methods Market

A detailed market share analysis in the Molecular Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Methods Market

A strategic analysis of the Molecular Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Molecular Methods Market, highlighting leading vendors and their innovative profiles. These include 3m Company, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, HiMedia Laboratories LLC, Invitae Corporation, Neogen Corporation, QIAGEN GmbH, Sekisui Chemical Co., Ltd., SGS SA, Siemens AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Molecular Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Biosensors, Immunoassay, Microarray, and Polymerase Chain Reaction.
  • Based on Product, market is studied across Instrument, Reagents & Consumables, and Services.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for food safety
      • 5.1.1.2. Rising prevalence of infectious diseases
      • 5.1.1.3. Increasing applications in environmental engineering
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory norms for approval
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D and advancements in molecular techniques
      • 5.1.3.2. Rising developments in genomics filed
    • 5.1.4. Challenges
      • 5.1.4.1. Intrinsic limitations of molecular methods
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Molecular Methods Market, by Technology

  • 6.1. Introduction
  • 6.2. Biosensors
  • 6.3. Immunoassay
  • 6.4. Microarray
  • 6.5. Polymerase Chain Reaction

7. Molecular Methods Market, by Product

  • 7.1. Introduction
  • 7.2. Instrument
  • 7.3. Reagents & Consumables
  • 7.4. Services

8. Americas Molecular Methods Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Molecular Methods Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Molecular Methods Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3m Company
  • 2. Abbott Laboratories
  • 3. Bio-Rad Laboratories, Inc.
  • 4. bioMerieux SA
  • 5. Danaher Corporation
  • 6. Eurofins Scientific
  • 7. F. Hoffmann-La Roche Ltd
  • 8. HiMedia Laboratories LLC
  • 9. Invitae Corporation
  • 10. Neogen Corporation
  • 11. QIAGEN GmbH
  • 12. Sekisui Chemical Co., Ltd.
  • 13. SGS SA
  • 14. Siemens AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MOLECULAR METHODS MARKET RESEARCH PROCESS
  • FIGURE 2. MOLECULAR METHODS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOLECULAR METHODS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOLECULAR METHODS MARKET DYNAMICS
  • TABLE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR METHODS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR METHODS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOLECULAR METHODS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR METHODS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023